The Angels' signing of Kirby Yates earns an **A+ CVI**, and the reasoning is straightforward once you strip away the noise surrounding his current injury status. Yes, five headlines are fixated on rehab timelines and a knee injury that has kept him off the mound, but the underlying value proposition here is undeniable — this is a low-cost flier on a pitcher who was among the most dominant closers in baseball during his 2019 campaign with San Diego. The media framing is cautiously optimistic for good reason: when Yates is healthy, his power reliever profile translates to genuine late-inning impact, the kind of addition that costs almost nothing but can pay enormous dividends if he rediscovers that elite form. The risk is real and transparent — his injury history is not a footnote but a central part of the story — yet the asymmetric upside of signing a former All-Star closer at presumably minimal cost is exactly the kind of high-ceiling, low-floor roster construction that earns top marks. An **A+ CVI** deal doesn't have to be a sure thing; it has to be a smart bet, and banking on Yates' talent while absorbing manageable downside is precisely that.
Cast your verdict:
Auto-moderated fan forum with 5-minute speaker turns
Loading discussion...